NeuroSense Therapeutics Ltd. Number Of Share Options Exercised In Share-based Payment Arrangement
NeuroSense Therapeutics Ltd. (NRSN) reported Number Of Share Options Exercised In Share-based Payment Arrangement of 12600000.00% for the 12-month period ending 2023-12-31, per its 20-F filed 2024-04-04.
Discontinued › Notes › Compensation Related Costs
ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement · last filed 2024-04-04
| Period end | Number Of Share Options Exercised In Share-based Payment Arrangement 12 month |
|---|---|
| 2023-12-31 | 12600000.00% 20-F · filed 2024-04-04 |